-
Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S, Spencer K, Avgidou K, Faiola S, Nicolaides KH.
Prenat Diagn 2005;25:977-83. -
Comparison of protocols for extracting circulating DNA and RNA from maternal plasma.
Chiu RW, Lui WB, El-Sheikhah A, Chan AT, Lau TK, Nicolaides KH, Lo YM.
Clin Chem 2005;51:2209-10. -
Aneuploidy screening in coelomic samples using fluorescence in situ hybridisation (FISH)
Chatzimeletiou K, Makrydimas G, Sotiriadis A, Paraskevaidis E, Nicolaides KH.
Prenat Diagn 2005;25:919-26. -
Placental expression of IFN-gamma and its receptor IFN-gammaR2 fail to switch from early hypoxic to late normotensive development in pre-eclampsia.
Banerjee S, Smallwood A, Moorhead J, Chambers AE, Papageorghiou A, Campbell S, Nicolaides K.
J Clin Endocrinol Metab 2005;90:944-52. -
Uterine artery Doppler and mid-trimester maternal plasma homocysteine in subsequent pre-eclampsia.
Yu CK, Lakasing L, Papageorghiou AT, Spencer K, Nicolaides KH.
J Matern Fetal Neonatal Med 2004;16:134-9. -
The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
Spencer K, Bindra R, Cacho AM, Nicolaides KH.
Prenat Diagn 2004;24:169-73. -
Umbilical cord diameter at 11-14 weeks of gestation: relation to chromosomal defects.
Rembouskos G, Cicero S, Papadopoulos V, Tripsanas C, Nicolaides KH.
Ultrasound Obstet Gynecol 2004;23:237-9. -
Assessment of the fetal nasal bone at 11-14 weeks of gestation by three-dimensional ultrasound.
Rembouskos G, Cicero S, Longo D, Vandecruys H, Nicolaides KH.
Ultrasound Obstet Gynecol 2004;23:232-6. -
The role of uterine artery Doppler in predicting adverse pregnancy outcome.
Papageorghiou AT, Yu CK, Nicolaides KH.
Best Pract Res Clin Obstet Gynaecol 2004;18:383-96. -
First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
Ong CY, Liao AW, Munim S, Spencer K, Nicolaides KH.
J Matern Fetal Neonatal Med 2004;15:176-80. -
Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.
Nicolaides KH.
Am J Obstet Gynecol 2004;191:45-67. -
Evaluation of human chorionic gonadotropin beta-subunit mRNA concentrations in maternal serum in aneuploid pregnancies: A feasibility study.
Ng EK, El-Sheikhah A, Chiu RW, Chan KC, Hogg M, Bindra R, Leung TN, Lau TK, Nicolaides KH, Lo YM.
Clin Chem 2004;50:1055-7. -
Assessment of efficacy of cell separation techniques used in the enrichment of foetal erythroblasts from maternal blood: triple density gradient vs single density gradient.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
Clin Lab Haematol 2004;26:123-8. -
Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency.
von Kaisenberg CS, Prols F, Nicolaides KH, Maass N, Meinhold-Heerlein I, Brand-Saberi B.
Hum Reprod 2003;18:2544-61. -
Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?
Spencer K, Bindra R, Nix AB, Heath V, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;22:142-8. -
Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience.
Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH.
BJOG 2003;110:281-6. -
Nasal bone length throughout gestation: normal ranges based on 3537 fetal ultrasound measurements.
Sonek JD, McKenna D, Webb D, Croom C, Nicolaides K.
Ultrasound Obstet Gynecol 2003;21:152-5. -
Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia.
Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH.
Lancet 2003;361:1511-7. -
Single umbilical artery at 11-14 weeks' gestation: relation to chromosomal defects.
Rembouskos G, Cicero S, Longo D, Sacchini C, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;22:567-70. -
Screening for chromosomal defects.
Nicolaides KH.
Ultrasound Obstet Gynecol 2003;21:313-21.